These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6641827)

  • 1. Isolation and characterisation of dimethylsulphoxide resistant variants from the human promyeloid cell line HL60.
    Bunce CM; Fisher AG; Toksoz D; Brown G
    Exp Hematol; 1983 Oct; 11(9):828-33. PubMed ID: 6641827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of human myeloid antigens using monoclonal antibodies and variant lines from the promyeloid cell line HL60.
    Fisher AG; Bunce CM; Toksoz D; Stone PC; Brown G
    Clin Exp Immunol; 1982 Nov; 50(2):374-81. PubMed ID: 7151330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
    Imaizumi M; Uozumi J; Breitman TR
    Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant cell lines from the human promyelocyte line HL60.
    Toksoz D; Bunce CM; Stone PC; Michell RH; Brown G
    Leuk Res; 1982; 6(4):491-8. PubMed ID: 6958930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
    Ahmed N; Williams JF; Weidemann MJ
    Biochem Int; 1991 Feb; 23(3):591-602. PubMed ID: 1652248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin receptor expression in HL60 cells induced to differentiate towards neutrophils or monocytes.
    Lord JM; Bunce CM; Duncan RJ; Phillips ID; Shennan KI; Docherty K; Brown G
    J Mol Endocrinol; 1988 Nov; 1(3):197-201. PubMed ID: 3255363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in phosphoproteins during commitment of HL60 cells to monocyte differentiation: evidence for multiple protein kinase involvement.
    Lord JM; Wong AK; Brown G
    Exp Hematol; 1988 Aug; 16(7):620-6. PubMed ID: 3164685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
    Ghezzo F; Palumbo A; Pegoraro L
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human system that generates O2- and induces 8-hydroxydeoxyguanosine, typical of oxidative DNA damage, by a tumor promotor.
    Takeuchi T; Nakajima M; Morimoto K
    Cancer Res; 1994 Nov; 54(22):5837-40. PubMed ID: 7954411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukaemia cell line.
    Burnett D; Crocker J; Vaughan AT
    J Cell Physiol; 1983 Jun; 115(3):249-54. PubMed ID: 6343405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytose Neisseria gonorrhoeae.
    Pantelic M; Chen I; Parker J; Zhang P; Grunert F; Chen T
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):261-6. PubMed ID: 15364113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone increased oxidative stress in a human cell line during differentiation.
    Izumo K; Horiuchi M; Komatsu M; Aoyama K; Bandow K; Matsuguchi T; Takeuchi M; Takeuchi T
    Free Radic Res; 2009 Oct; 43(10):922-31. PubMed ID: 19680996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of calcium and secretory responses in the human promyelocytic leukemia cell line HL60.
    Naccache PH; Molski TF; Spinelli B; Borgeat P; Abboud CN
    J Cell Physiol; 1984 May; 119(2):241-6. PubMed ID: 6325475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells.
    Slosberg ED; Yao Y; Xing F; Ikui A; Jirousek MR; Weinstein IB
    Mol Carcinog; 2000 Mar; 27(3):166-76. PubMed ID: 10708478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase activity increases in HL60 cells induced to differentiate with retinoic acid and TPA but not with DMSO.
    Maddox AM; Haddox MK
    Exp Cell Biol; 1985; 53(5):294-300. PubMed ID: 2864293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells.
    Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K
    Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.
    Banerjee D; Lenz HJ; Schnieders B; Manno DJ; Ju JF; Spears CP; Hochhauser D; Danenberg K; Danenberg P; Bertino JR
    Cell Growth Differ; 1995 Nov; 6(11):1405-13. PubMed ID: 8562479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a differentiation-specific cell surface antigen on HL60 cells that is associated with proliferation.
    Todd MB; Malech HL
    Cancer Res; 1986 Jan; 46(1):113-8. PubMed ID: 3455664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminol-dependent chemiluminescence of human phagocyte cell lines: comparison between DMSO differentiated PLB 985 and HL 60 cells.
    Ashkenazi A; Marks RS
    Luminescence; 2009; 24(3):171-7. PubMed ID: 19291810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.